- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Q1 2021 Novo Nordisk A/S Earnings Call Transcript
Hello, and welcome to the Q1 2021 Novo Nordisk A/S earnings conference call. (Operator Instructions) Today, I'm pleased to present Lars Fruergaard Jørgensen. Please go ahead with your meeting.
/- -
Thank you very much, and welcome to this Novo Nordisk Earnings Call for the first 3 months of 2021 and outlook for the year. I'm Lars Fruergaard Jørgensen, the CEO of Novo Nordisk. With me I have our Chief Financial Officer, Karsten Munk Knudsen; and Executive Vice President and Head of Development, Martin Holtz Lange. Also present and available for Q&A session is Executive Vice President and Head of Commercial Strategy and Corporate Affairs, Camilla Sylvest.
Today's earnings release and the slides for this call are available on our website, novonordisk.com. Please note that this call is being webcasted live and this call -- and the recording will be made available on Novo Nordisk's website. The call is scheduled to last 1
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |